38 related articles for article (PubMed ID: 611665)
21. Iron metabolism and chelation therapy in hemosiderosis.
Graziano JH
Curr Top Hematol; 1978; 1():127-50. PubMed ID: 400529
[No Abstract] [Full Text] [Related]
22. Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload.
Nienhuis AW; Delea C; Aamodt R; Bartter F; Anderson WF
Birth Defects Orig Artic Ser; 1976; 12(8):177-85. PubMed ID: 795481
[No Abstract] [Full Text] [Related]
23. [Use of desferal in treatment of sideroses of different origin. (Literature review)].
Turbina NS
Probl Gematol Pereliv Krovi; 1968 Jul; 13(7):47-52. PubMed ID: 4898933
[No Abstract] [Full Text] [Related]
24. Clinical management of beta-thalassemia.
Graziano J; Piomelli S
Tex Rep Biol Med; 1980-1981; 40():355-64. PubMed ID: 7034276
[No Abstract] [Full Text] [Related]
25. Detoxification in hemosiderosis.
Simon P
Blood Purif; 1985; 3(1-3):75-88. PubMed ID: 3913449
[TBL] [Abstract][Full Text] [Related]
26. Results of long-term subcutaneous desferrioxamine therapy.
Hoffbrand AV; Wonke B
Baillieres Clin Haematol; 1989 Apr; 2(2):345-62. PubMed ID: 2660932
[TBL] [Abstract][Full Text] [Related]
27. Clinical removal of iron.
Propper R; Nathan D
Annu Rev Med; 1982; 33():509-19. PubMed ID: 6282184
[No Abstract] [Full Text] [Related]
28. Current therapy of Cooley's anemia. A decade of experience with subcutaneous desferrioxamine.
Giardina PJ; Grady RW; Ehlers KH; Burstein S; Graziano JH; Markenson AL; Hilgartner MW
Ann N Y Acad Sci; 1990; 612():275-85. PubMed ID: 2291555
[No Abstract] [Full Text] [Related]
29. Transfusional iron overload.
Marcus RE; Huehns ER
Clin Lab Haematol; 1985; 7(3):195-212. PubMed ID: 3907937
[No Abstract] [Full Text] [Related]
30. Clinical manifestations and therapy of transfusional haemosiderosis.
Gabutti V; Borgna-Pignatti C
Baillieres Clin Haematol; 1994 Dec; 7(4):919-40. PubMed ID: 7881160
[TBL] [Abstract][Full Text] [Related]
31. Modern management of thalassemia.
Festa RS
Pediatr Ann; 1985 Sep; 14(9):597-600, 602-3, 606. PubMed ID: 3903631
[No Abstract] [Full Text] [Related]
32. [Congenital atransferrinemia].
Hromec A; Payer J; Killinger Z; Rybár I; Rovenský J
Dtsch Med Wochenschr; 1994 May; 119(18):663-6. PubMed ID: 8187613
[TBL] [Abstract][Full Text] [Related]
33. Current concepts in the management of thalassemia.
Festa RS
Indian J Pediatr; 1987; 54(3):379-89. PubMed ID: 3301658
[No Abstract] [Full Text] [Related]
34. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
Trans Assoc Am Physicians; 1977; 90():335-41. PubMed ID: 611665
[No Abstract] [Full Text] [Related]
35. Iron metabolism and iron chelation in the thalassaemia disorders.
Pippard MJ
Haematologica; 1990; 75 Suppl 5():66-71. PubMed ID: 2086383
[No Abstract] [Full Text] [Related]
36. The treatment of Cooley's anemia.
Nathan DG
Haematologica; 1990; 75 Suppl 5():57-65. PubMed ID: 2086382
[No Abstract] [Full Text] [Related]
37. [Recommendations for therapy of juvenile thalassemia major].
Siller V; Frank M
Fortschr Med; 1980 Nov; 98(44):1720-9. PubMed ID: 7007189
[TBL] [Abstract][Full Text] [Related]
38. [Sideroblastic anemias].
Löhr GW
Verh Dtsch Ges Inn Med; 1978; (84):71-8. PubMed ID: 369209
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
